Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus
Tóm tắt
Antidepressants have been shown to affect levels of brain-derived neurotrophic factor (BDNF) and VGF (non-acronymic) whose transcriptions are dependent on cAMP response element binding protein (CREB) in long term treatment. The aim of this study was to verify the subacute antidepressant effects of crocin, an active constituent of saffron (
Crocin (12.5, 25, and 50 mg/kg), imipramine (10 mg/kg; positive control) and saline (1 mL/kg; neutral control) were administered intraperitoneally (IP) to male Wistar rats for 21 days. The antidepressant effects were studied using the forced swimming test (FST) on day 21 after injection. Protein expression and transcript levels of genes in the rat hippocampus were evaluated using western blot and quantitative reverse transcription-polymerase chain reaction (qRT-PCR), respectively.
Crocin significantly reduced the immobility time in the FST. Western blot analysis showed that 25 and 50 mg/kg of crocin increased the levels of CREB and BDNF significantly and dose dependently. All doses of crocin increased the VGF levels in a dose-dependent manner. Levels of p-CREB increased significantly by 50 mg/kg dose of crocin. Only 12.5 mg/kg crocin could significantly increase the transcript levels of BDNF. No changes in CREB and VGF transcript levels were observed in all groups.
These results suggest that crocin has antidepressant-like action by increasing CREB, BDNF and VGF levels in hippocampus.
Từ khóa
Tài liệu tham khảo
Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990–2020: global burden of disease study. Lancet. 1997, 349: 1498-1504. 10.1016/S0140-6736(96)07492-2.
Demyttenaere K: Compliance during treatment with antidepressants. J Affect Disord. 1997, 43: 27-39. 10.1016/S0165-0327(96)00095-X.
Blackwell B: Antidepressant drugs: side effects and compliance. J Clin Psychiatry. 1982, 43: 14-21.
Schulz V: Safety of St John’s Wort extract compared to synthetic antidepressants. Phytomedicine. 2006, 13: 199-204. 10.1016/j.phymed.2005.07.005.
Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H: Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008, 15: 1032-1037. 10.1016/j.phymed.2008.06.003.
Schechter LE, Ring RH, Beyer CE, Hughes ZA, Khawaja X, Malberg JE, Rosenzweig-Lipson S: Innovative approaches for the development of antidepressant drugs: current and future strategies. NeuroRx. 2005, 2: 590-611. 10.1602/neurorx.2.4.590.
Thakker-Varia S, Alder J: Neuropeptides in depression: role of VGF. Behav Brain Res. 2009, 197: 262-278. 10.1016/j.bbr.2008.10.006.
Dranovsky A, Hen R: Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry. 2006, 59: 1136-1143. 10.1016/j.biopsych.2006.03.082.
Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F: Strategies for producing faster acting antidepressants. Drug Discov Today. 2005, 10: 578-585. 10.1016/S1359-6446(05)03398-2.
Blendy JA: The role of CREB in depression and antidepressant treatment. Biol Psychiatry. 2006, 59: 1144-1150. 10.1016/j.biopsych.2005.11.003.
Yu H, Chen ZY: The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin. 2011, 32: 3-11. 10.1038/aps.2010.184.
Hosseinzadeh H, Nassiri-Asl M: Avicenna’s (Ibn Sina) the Canon of Medicine and Saffron (Crocus sativus): a review. Phytother Res. 2013, 27: 475-483. 10.1002/ptr.4784.
Rezaee R, Hosseinzadeh H: Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci. 2013, 16: 12-26.
Behravan J, Hosseinzadeh H, Rastgoo A, Hessani M: Evaluation of the cytotoxic activity of crocin and safranal using potato disc and brine shrimp assays. Physiol Pharmacol. 2010, 13: 397-403.
Garcia-Olmo DC, Riese HH, Escribano J, Ontanon J, Fernandez JA, Atienzar M, Garcia-Olmo D: Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. Nutr Cancer. 1999, 35: 120-126. 10.1207/S15327914NC352_4.
Hosseinzadeh H, Behravan J, Ramezani M, Ajgan K: Anti-tumor and cytotoxic evaluation of Crocus sativus L. stigma and petal extracts using brine shrimp and potato disc assays. J Med Plants. 2005, 4: 59-65.
Rastgoo M, Hosseinzadeh H, Alavizadeh H, Abbasi A, Ayati Z, Jaafari MR: Antitumor Activity of PEGylated Nanoliposomes Containing Crocin in Mice Bearing C26 Colon Carcinoma. Planta medica. 2013, 79: 447-451.
Salomi MJ, Nair SC, Panikkar KR: Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr Cancer. 1991, 16: 67-72. 10.1080/01635589109514142.
Hosseinzadeh H, Shamsaie F, Mehri S: Antioxidant activity of aqueous and ethanolic extracts of Crocus sativus L. stigma and its bioactive constituents, crocin and safranal. Pharmacogn Mag. 2009, 5: 419-424.
Amin B, Hosseinzadeh H: Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia. 2012, 83: 888-895. 10.1016/j.fitote.2012.03.022.
Hosseinzadeh H, Younesi HM: Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacol. 2002, 2: 7-
Hosseinzadeh H, Ziaee T, Sadeghi A: The effect of saffron, Crocus sativus stigma, extract and its constituents, safranal and crocin on sexual behaviors in normal male rats. Phytomedicine. 2008, 15: 491-495. 10.1016/j.phymed.2007.09.020.
Hosseinzadeh H, Ghenaati J: Evaluation of the antitussive effect of stigma and petals of saffron (Crocus sativus) and its components, safranal and crocin in guinea pigs. Fitoterapia. 2006, 77: 446-448. 10.1016/j.fitote.2006.04.012.
Imenshahidi M, Hosseinzadeh H, Javadpour Y: Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytother Res. 2010, 24: 990-994.
Mehdizadeh R, Parizadeh MR, Khooei A-R, Mehri S, Hosseinzadeh H: Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats. Iran J Basic Med Sci. 2013, 16: 56-63.
Razavi M, Hosseinzadeh H, Abnous K: Sadat Motamedahariaty V, Imenshahidi M: Crocin Restores Hypotensive Effect of Subchronic Administration of Diazinon in Rats. Iran J Basic Med Sci. 2012, 16: 64-72.
Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, Motamedshariaty VS, Mohajeri SA: Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res. 2012, 26: 381-386.
Hosseinzadeh H, Ziaei T: Effects of Crocus sativus stigma extract and its constituents, crocin and safranal, on intact memory and scopolamine-induced learning deficits in rats performing the Morris water maze task. J Med Plants. 2006, 5: 40-50.
Hosseinzadeh H, Noraei NB: Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009, 23: 768-774. 10.1002/ptr.2597.
Hosseinzadeh H, Jahanian Z: Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res. 2010, 24: 726-730.
Imenshahidi M, Zafari H, Hosseinzadeh H: Effects of crocin on the acquisition and reinstatement of morphine-induced conditioned place preference in mice. Pharmacologyonline. 2011, 1: 1007-1013.
Hosseinzadeh H, Talebzadeh F: Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia. 2005, 76: 722-724. 10.1016/j.fitote.2005.07.008.
Hosseinzadeh H, Karimi G, Niapoor M: Antidepressant effects of Crocus sativus stigma extracts and its constituents, crocin and safranal, in mice. J Med Plants. 2004, 3: 48-58.
Hosseinzadeh H, Motamedshariaty V, Hadizadeh F: Antidepressant effect of kaempferol, a constituent of saffron (Crocus sativus) petal, in mice and rats. Pharmacologyonline. 2007, 2: 367-370.
Karimi GR, Hosseinzadeh H, Khaleghpanah P: Study of antidepressant effect of aqueous and ethanolic extract of Crocus sativus in mice. Iran J Basic Med Sci. 2001, 4: 11-15.
Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL, Rahman K, Qin LP: Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med. 2010, 64: 24-30. 10.1007/s11418-009-0360-6.
Hadizadeh F, Mohajeri SA, Seifi M: Extraction and purification of crocin from saffron stigmas employing a simple and efficient crystallization method. Pak J Biol Sci. 2010, 13: 691-698.
Pitsikas N, Sakellaridis N: Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat. Behav Brain Res. 2006, 173: 112-115. 10.1016/j.bbr.2006.06.005.
Fortunato JJ, Reus GZ, Kirsch TR, Stringari RB, Fries GR, Kapczinski F, Hallak JE, Zuardi AW, Crippa JA, Quevedo J: Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus. J Neural Transm. 2010, 117: 1131-1137. 10.1007/s00702-010-0451-2.
Nakamura K, Tanaka Y: Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology (Berl). 2001, 158: 205-212. 10.1007/s002130100849.
Porsolt RD, Le Pichon M, Jalfre M: Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977, 266: 730-732. 10.1038/266730a0.
Detke MJ: Rickels M, Lucki I: Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl). 1995, 121: 66-72. 10.1007/BF02245592.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.
Yee BK, Zhu SW, Mohammed AH, Feldon J: Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice. J Neural Transm. 2007, 114: 431-444. 10.1007/s00702-006-0548-9.
Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995, 15: 1768-1777.
Videbech P, Ravnkilde B: Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004, 161: 1957-1966. 10.1176/appi.ajp.161.11.1957.
Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW: Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 1996, 93: 3908-3913. 10.1073/pnas.93.9.3908.
Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS: Hippocampal volume reduction in major depression. Am J Psychiatry. 2000, 157: 115-118.
Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M, Racagni G, Popoli M: Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology. 2004, 29: 1831-1840. 10.1038/sj.npp.1300488.
Nibuya M, Nestler EJ, Duman RS: Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 1996, 16: 2365-2372.
Reus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J: Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res. 2011, 221: 166-171. 10.1016/j.bbr.2011.02.024.
Blom JM, Tascedda F, Carra S, Ferraguti C, Barden N, Brunello N: Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. Neuropsychopharmacology. 2002, 26: 605-614. 10.1016/S0893-133X(01)00401-8.
Davies AM: The role of neurotrophins in the developing nervous system. J Neurobiol. 1994, 25: 1334-1348. 10.1002/neu.480251103.
Aydemir O, Deveci A, Taneli F: The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 2005, 29: 261-265. 10.1016/j.pnpbp.2004.11.009.
Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F: Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology. 2005, 51: 234-238. 10.1159/000085725.
Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ: Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology. 2004, 29: 2189-2199. 10.1038/sj.npp.1300514.
Coppell AL, Pei Q, Zetterstrom TS: Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology. 2003, 44: 903-910. 10.1016/S0028-3908(03)00077-7.
Allaman I, Fiumelli H, Magistretti PJ, Martin JL: Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl). 2011, 216: 75-84. 10.1007/s00213-011-2190-y.